The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...
Bacteriophages are infectious agents that comprise viruses that infect bacteria. Bacteriophages are widespread, abundant and very diverse. The potential roles of viruses in microbial-induced ...